MassBio is partnering with Novo Nordisk on October 26 to host Novo Nordisk Pharma Day 2023, an unparalleled opportunity for emerging innovators to learn from and connect with a leading global healthcare company that is driving change to defeat serious chronic diseases.
What they’re saying: “Novo Nordisk has partnered with leading scientists for 100 years to transform innovative ideas into groundbreaking therapies. We are always looking for high-potential innovation and strategic partnerships to complement our existing capabilities. With our best-in-class research and development organization and global reach we are the right partner to bring innovative ideas to life and help unlock their full potential.”
– John McDonald, Head of Business Development and M&A at Novo Nordisk
Hear the latest: At Novo Nordisk’s open information session you will discover the latest insights on its R&D strategy, priority therapeutic areas, and partnering capabilities. This session will be followed by a networking reception.
- Register to attend the information session and reception today
Get closer: Groundbreaking innovators across all stages of development with any therapeutic modality can apply for a one-on-one meeting with Novo Nordisk’s representatives during the day. Novo Nordisk’s priority therapeutic areas are:
- Rare blood disorders
- Cardiovascular diseases
- Other serious chronic diseases (CKD, NASH)
If your company meets their eligibility guidelines, apply for a 1:1 meeting by September 8, 2023 at 5:00PM ET.